Dr. B Gijbels

Active

Private limited companyfounded 2019active for 7 yearsGasterbosstraat 6, 3540 Herk-de-Stad, BelgiumKBO/BCE: BE 0731.658.231

Summary

Dr. B Gijbels has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,000 and a net result of €106,502. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 8% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. B GijbelsActiveChecked score 92/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

1 site

Size

€144,170total assets 2025

Equity: €5,000
Profit: €106,502

Turnover not published (micro format)

Financial health

92 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

2025 accounts 129 days early1 deed in the Belgian Official Gazette

Why 92raises riskEquity €5,000 (3.5% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €144,170Liquidity: current ratio 0.27, cash €25,742, halvedShow the evidence

Checked score

Score 2025

92 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 33% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Average

Solvency 28+1

equity 3.5% of total assets

Liquidity 30-13

short-term debt 77.7% · cash 17.9%

Profitability 100=

return on assets 73.9%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025highest value 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: < 0.1%▼ -0.1 percentage points vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 9% on solvency, 6% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

Size: total assets €144,170

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Equity €5,000 (3.5% of total assets)

NBB · annual accounts

Liquidity: current ratio 0.27, cash €25,742, halved

NBB · annual accounts

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 8% of 20612 sector peers (2025).

NBB · sector comparison

Position among 20612 sector peers

Solvency

better than 8%

← weakest strongest →

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-03-2026, 129 days ahead of the deadline.

NBB · 7 filings

Deviation from the deadline

2025

129 days early

2024

112 days early

2023

90 days early

2022

34 days early

2021

3 days early

2020

31 days late

2019

69 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 38 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 May (4 of the last 5 filed years within 55 days of that day).

Companies Code · seven months

Where today falls in the filing period

26-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

24-03-2026 Annual accounts filedfinancial year 2025 · micro…
31-12-2025 Highest result from 2019 to 2025net €106,502 ▲7%
10-04-2025 Annual accounts filedfinancial year 2024 · micro…

Key points

Caution: Among the weakest 9% on solvencysector median 63.0% · 20,612 companies 3.5% View
Positive: 7 profitable years in a rowprofit 2025: €106,502 7 years View
Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

By topic

Financials

Financial year: 2025
Total assets: €144,170
Profit: €106,502
Solvency: 3.5%

Total assets▼ 32.3%

Net result

20192025

Go to Financials

Timeline

Events: 12
Since: 2020
Next accounts: by 31-07-2027

02-05-2024Annual accounts filed
27-06-2023Annual accounts filed
28-07-2022Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 29-07-2019
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about Dr. B Gijbels

What is the company number of Dr. B Gijbels?: 0731.658.231. In Belgium the VAT number is the company number with BE in front: BE 0731.658.231.
Where is Dr. B Gijbels based?: The registered office is at Gasterbosstraat 6, 3540 Herk-de-Stad.Company details
What does Dr. B Gijbels do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. B Gijbels?: Private limited company (BV).
When was Dr. B Gijbels founded?: On 29-07-2019.
Is Dr. B Gijbels still active?: Yes, Dr. B Gijbels is an active enterprise in the KBO register.
What is the turnover of Dr. B Gijbels?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. B Gijbels profitable?: In financial year 2025, Dr. B Gijbels made a profit of €106,502.
Where can I find the annual accounts of Dr. B Gijbels?: Dr. B Gijbels filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. B Gijbels due?: By 31-07-2027, for financial year 2026.Timeline